Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-17

Clinical Trial Update: Retraining and Control Therapy (ReACT) R33 Phase [NA]

View source ↗

Summary

A university-sponsored clinical trial called Retraining and Control Therapy (ReACT) R33 is currently recruiting to evaluate a non-pharmacologic intervention for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Convulsion, Non-Epileptic | NA | Status: RECRUITING